Skip to main content
Premium Trial:

Request an Annual Quote

Tripos Announces Deals with GSK, Schering-Plough, Others

NEW YORK, Jan. 25 (GenomeWeb News) - Tripos today announced a series of new and extended collaborations with five US and European pharmaceutical and life sciences companies.


The St. Louis-based company said it will work with GlaxoSmithKline, Schering-Plough, Genzyme, Cenes, and Gemin X Biotechnologies to deliver customized chemistry services.


Specifically, Tripos said the activities with its partners will include medicinal chemistry programs, the development of Tripos' new compounds for its small molecule screening collection, and the creation of follow-up libraries based on hits from LeadQuest.


Financial details were not disclosed.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.